Trade tiffs, Covid jab export bans leave Africa vulnerable

Covid-19 vaccine.

A Kenyan health worker administers the Oxford/AstraZeneca vaccine to colleagues to help fight coronavirus at the Kenyatta National Hospital in Nairobi on March 5, 2021. PHOTO | FILE

From fresh export bans to a fight over how best to use the global intellectual property (IP) system to tackle the Covid-19 pandemic, poor nations especially in Africa sit vulnerable especially at time when a third deadly wave of infections sweeps across the world.

As the EU tighten Covid-19 vaccine export rules on the account of rising third wave of infections, several developed nations including the US, UK, Switzerland, Canada and their allies continue to block a proposal by developing countries to temporarily suspend the World Trade Organisation (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement to enable greatly increased, affordable supplies of Covid-19 vaccines, drugs, tests and equipment.

PAYE Tax Calculator

Note: The results are not exact but very close to the actual.